These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37013729)

  • 21. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells.
    Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P
    Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translation-dependent skin hyperplasia is promoted by type 1/17 inflammation in psoriasis.
    Xu R; Li X; Huang X; Lin Z; Xiong Y; Chen X; Chu C; Han J; Wang F
    J Dermatol Sci; 2023 Apr; 110(1):10-18. PubMed ID: 37024314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allicin ameliorates imiquimod-induced psoriasis-like skin inflammation via disturbing the interaction of keratinocytes with IL-17A.
    Zhang L; Ma X; Shi R; Zhang L; Zhao R; Duan R; Qin Y; Gao S; Li X; Duan J; Li J
    Br J Pharmacol; 2023 Mar; 180(5):628-646. PubMed ID: 36355777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RPL22 Overexpression Promotes Psoriasis-Like Lesion by Inducing Keratinocytes Abnormal Biological Behavior.
    Zeng J; Zhang Y; Zhang H; Zhang Y; Gao L; Tong X; Xie Y; Hu Q; Chen C; Ding S; Lu J
    Front Immunol; 2021; 12():699900. PubMed ID: 34220863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1/Th17 cell population and keratinocyte activation.
    Kim N; Lee S; Kang J; Choi YA; Lee B; Kwon TK; Jang YH; Kim SH
    Int Immunopharmacol; 2020 Oct; 87():106767. PubMed ID: 32679548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PARP2 promotes inflammation in psoriasis by modulating estradiol biosynthesis in keratinocytes.
    Antal D; Pór Á; Kovács I; Dull K; Póliska S; Ujlaki G; Demény MÁ; Szöllősi AG; Kiss B; Szegedi A; Bai P; Szántó M
    J Mol Med (Berl); 2023 Aug; 101(8):987-999. PubMed ID: 37351597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
    Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
    Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sprouty1 exerts a preventive effect on the initiation of psoriasis by inhibiting innate immune antimicrobial peptide cathelicidin and immunocytes.
    Zhou Y; Wang P; Chen XY; Yan BX; Landeck L; Wang ZY; Xu F; Zheng M; Man XY
    Cell Prolif; 2022 Oct; 55(10):e13290. PubMed ID: 35716036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical VX-509 attenuates psoriatic inflammation through the STAT3/FABP5 pathway in keratinocytes.
    Yan B; Liu P; Yi X; Li J; Liu N; Zhu W; Kuang Y; Chen X; Peng C
    Pharmacol Res; 2022 Aug; 182():106318. PubMed ID: 35728766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eupatilin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like skin lesions in mice via the p38 MAPK/NF-κB signaling pathway.
    Bai D; Cheng X; Li Q; Zhang B; Zhang Y; Lu F; Sun T; Hao J
    Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):133-139. PubMed ID: 36305632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
    Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
    Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation.
    Cibrian D; Castillo-González R; Fernández-Gallego N; de la Fuente H; Jorge I; Saiz ML; Punzón C; Ramírez-Huesca M; Vicente-Manzanares M; Fresno M; Daudén E; Fraga-Fernandez J; Vazquez J; Aragonés J; Sánchez-Madrid F
    J Allergy Clin Immunol; 2020 Jan; 145(1):199-214.e11. PubMed ID: 31605740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Critical Role of the IL-1β-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis.
    Cai Y; Xue F; Quan C; Qu M; Liu N; Zhang Y; Fleming C; Hu X; Zhang HG; Weichselbaum R; Fu YX; Tieri D; Rouchka EC; Zheng J; Yan J
    J Invest Dermatol; 2019 Jan; 139(1):146-156. PubMed ID: 30120937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PDRN, a Bioactive Natural Compound, Ameliorates Imiquimod-Induced Psoriasis through NF-κB Pathway Inhibition and Wnt/β-Catenin Signaling Modulation.
    Irrera N; Bitto A; Vaccaro M; Mannino F; Squadrito V; Pallio G; Arcoraci V; Minutoli L; Ieni A; Lentini M; Altavilla D; Squadrito F
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of Wilms' tumor 1 in skin lesions of psoriasis is associated with abnormal proliferation and apoptosis of keratinocytes.
    Wu R; Liao Y; Shen W; Liu Y; Zhang J; Zheng M; Chen G; Su Y; Zhao M; Lu Q
    Mol Med Rep; 2018 Oct; 18(4):3973-3982. PubMed ID: 30132523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model.
    Wu S; Zhao M; Sun Y; Xie M; Le K; Xu M; Huang C
    Life Sci; 2020 Jan; 241():117115. PubMed ID: 31790685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hesperidin inhibits keratinocyte proliferation and imiquimod-induced psoriasis-like dermatitis via the IRS-1/ERK1/2 pathway.
    Li X; Xie X; Zhang L; Meng Y; Li N; Wang M; Zhai C; Liu Z; Di T; Zhang L; Li P
    Life Sci; 2019 Feb; 219():311-321. PubMed ID: 30658103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein Kinase CK2 Promotes Proliferation, Abnormal Differentiation, and Proinflammatory Cytokine Production of Keratinocytes via Regulation of STAT3 and Akt Pathways in Psoriasis.
    Huang W; Zheng X; Huang Q; Weng D; Yao S; Zhou C; Li Q; Hu Y; Xu W; Huang K
    Am J Pathol; 2023 May; 193(5):567-578. PubMed ID: 37080661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis.
    Itoh T; Hatano R; Komiya E; Otsuka H; Narita Y; Aune TM; Dang NH; Matsuoka S; Naito H; Tominaga M; Takamori K; Morimoto C; Ohnuma K
    J Invest Dermatol; 2019 Apr; 139(4):878-889. PubMed ID: 30423328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-α/IFN-γ-induced inflammatory response in keratinocytes and T cell-derived IL-17.
    Lin ZM; Ma M; Li H; Qi Q; Liu YT; Yan YX; Shen YF; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP
    Pharmacol Res; 2018 Mar; 129():443-452. PubMed ID: 29155016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.